AMG 510 Well Tolerated by Patients With NSCLC
A phase 1 trial found that AMG 510 is tolerated in patients with previously treated non-small cell lung cancer.
Diagnosis & Disease Information
Neutrophil Lymphocyte Ratio May Predict Lung Cancer Overall Survival
Researchers found that NLR before treatment was significantly associated with overall survival and progression-free survival.
Flu Vaccine Does Not Increase Risk of Adverse Events in Patients With Lung Cancer
A retrospective analysis supports the administration of flu vaccination in patients with lung cancer on ICI therapy.
Circulating Autoantibodies Could Predict Patient Response to Immunotherapy
Researchers found that IMP2, a cancer autoantibody, was significantly associated with time to progression in patients with NSCLC treatment with non-frontline PD-1/PD-L1.
Pembrolizumab Improves Survival in NSCLC When Combined With Chemotherapy
Researched conducted a post hoc pooled analysis of 3 KEYNOTE cohorts and found the addition of pembrolizumab improved OS and PFS in patients with NSCLC.
- Loading...
Loading...
Next post in IASLC North America 2019
Loading... 
Loading...